Characterization of the Antioxidant Effects of γ-Oryzanol: Involvement of the Nrf2 Pathway

Article English OPEN
Rungratanawanich, W.; Abate, G.; Serafini, M. M.; Guarienti, M.; Catanzaro, M.; Marziano, M.; Memo, M.; Lanni, C.; Uberti, D.;

γ-Oryzanol (ORY) is well known for its antioxidant potential. However, the mechanism by which ORY exerts its antioxidant effect is still unclear. In this paper, the antioxidant properties of ORY were investigated for its potential effects as a reactive oxygen and nitrog... View more
  • References (46)
    46 references, page 1 of 5

    [1] D. Harman, “Aging: a theory based on free radical and radiation chemistry,” Journal of Gerontology, vol. 11, no. 3, pp. 298-300, 1956.

    [2] R. Olinski, A. Siomek, R. Rozalski et al., “Oxidative damage to DNA and antioxidant status in aging and age-related diseases,” Acta Biochimica Polonica, vol. 1, pp. 11-26, 2007.

    [3] B. Uttara, A. Singh, P. Zamboni, and R. Mahajan, “Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options,” Current Neuropharmacology, vol. 7, no. 1, pp. 65-74, 2009.

    [4] G. Cenini, C. Cecchi, A. Pensalfini et al., “Generation of reactive oxygen species by beta amyloid fibrils and oligomers involves different intra/extracellular pathways,” Amino Acids, vol. 38, no. 4, pp. 1101-1106, 2010.

    [5] J. M. McCord, “The evolution of free radicals and oxidative stress,” The American Journal of Medicine, vol. 108, no. 8, pp. 652-659, 2000.

    [6] Y. Z. Fang, S. Yang, and G. Wu, “Free radicals, antioxidants, and nutrition,” Nutrition, vol. 18, no. 10, pp. 872-879, 2002.

    [7] N. Ghosh, R. Ghosh, and S. C. Mandal, “Antioxidant protection: a promising therapeutic intervention in neurodegenerative disease,” Free Radical Research, vol. 45, no. 8, pp. 888-905, 2011.

    [8] J. I. Castillo-Quan, K. J. Kinghorn, and I. Bjedov, “Genetics and pharmacology of longevity,” Advances in Genetics, vol. 90, pp. 1-101, 2015.

    [9] D. R. Bruns, J. C. Drake, L. M. Biela, F. F. Peelor, B. F. Miller, and K. L. Hamilton, “Nrf2 signaling and the slowed aging phenotype: evidence from long-lived models,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 732596, 15 pages, 2015.

    [10] G. P. Sykiotis, I. G. Habeos, A. V. Samuelson, and D. Bohmann, “The role of the antioxidant and longevitypromoting Nrf2 pathway in metabolic regulation,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14, no. 1, pp. 41-48, 2011.

  • Related Organizations (4)
  • Metrics